Canadian Psychiatric Association
 

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)


Guest Editorial
Needed: Clinical Research in Mood Disorders

Martin Alda, Michael Bauer

(PDF)


In Review
The Antisuicidal and Mortality-Reducing Effect of Lithium Prophylaxis: Consequences for Guidelines in Clinical Psychiatry

Bruno Müller-Oerlinghausen, Anne Berghöfer, Bernd Ahrens

(PDF)

Lithium Augmentation Therapy in Refractory Depression: Clinical Evidence and Neurobiological Mechanisms
Michael Bauer, Mazda Adli, Christopher Baethge, Anne Berghöfer, Johanna Sasse, Andreas Heinz, Tom Bschor

(PDF)

Prophylaxis Latency and Outcome in Bipolar Disorders
Christopher Baethge, Leonardo Tondo, Irene M Bratti, Tom Bschor, Michael Bauer, Adele C Viguera, Ross J Baldessarini

(PDF)


Review Paper
Clinical Features of Bipolar Disorder With and Without Comorbid Diabetes Mellitus

Martina Ruzickova, Claire Slaney, Julie Garnham, Martin Alda

(PDF)


The Cortisol Awakening Response in Bipolar Illness: A Pilot Study

Dorian Deshauer, Anne Duffy, Martin Alda, Eva Grof, Joy Albuquerque, Paul Grof

(PDF)


Implementing Quality Management in Psychiatry: From Theory to Practice—Shifting Focus From Process to Outcome

Brent M McGrath, Raymond P Tempier

(PDF)


Original Research
Mental Disorders and Reasons for Using Complementary Therapy

Badri Rickhi, Hude Quan, Sabine Moritz, Heather L Stuart, Julio Arboleda-Flórez

(PDF)

Readiness to Participate in Psychiatric Research Daniele Zullino, Philippe Conus, François Borgeat, Charles Bonsack
(PDF)

Toward Benchmarks for Tertiary Care for Adults With Severe and Persistent Mental Disorders
Alain D Lesage, Daniel Gélinas, David Robitaille, Éric Dion, Diane Frezza, Raymond Morissette

(PDF)


Brief Communication
Patient Attitudes Regarding Causes of Depression: Implications for Psychoeducation

Janaki Srinivasan, Nicole L Cohen, Sagar V Parikh

(PDF)


Book Reviews
(PDF)

Helping the Helpers Not to Harm: Iatrogenic Damage and Community Mental Health.
Reviewed by
Peter Moore, MD, FRCPC

L’Homme de Vérité.
Revue par
Maurice Dongier, MD, FRCPC


Letters to the Editor
(PDF)

Re: The Combined Use of Atypical Antipsychotics and Cognitive-Behavioural Therapy in Schizophrenia

Reply: The Combined Use of Atypical Antipsychotics and Cognitive-Behavioural Therapy in Schizophrenia

Re: Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists

Reply: Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists

Re: Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists

Reply: Should Psychologists Be Granted Prescription Privileges? A Review of the Prescription Privilege Debate for Psychiatrists

Breath-Holding in Anxiety Disorders

Bright Light, Serotonin Turnover, and Psychological Well-Being

Letters to the Editor

Re: The Combined Use of Atypical Antipsychotics and Cognitive-Behavioural Therapy in Schizophrenia

Dear Editor:

We read with interest Dr Duggal’s letter on the combined use of atypical antipsychotics (AAs) and cognitive- behavioural therapy (CBT) in schizophrenia (1). Dr Duggal reports that his patient showed a reduction of 54% in symptom severity as indexed by the Positive and Negative Syndrome Scale (PANSS). His baseline score when unmedicated was 129 and varied from 83 to 102 with medication; when medication was combined with CBT, his PANSS score was 59.

Dr Duggal’s finding is consistent with, and adds to, the existing literature on the combined use of second-generation antipsychotics (SGAs) and CBT. Our Symptom-Specific Group Treatment Program (conducted at Bronx Psychiatric Center) was designed to match the 5 symptom dimensions of the PANSS: positive, negative, activation, dysphoria, and autistic preoccupation (2). We found that patients attending symptom-specific groups in addition to receiving standard medications showed an additional 22% decrease in symptom severity when compared with a group of patients receiving standard medications alone (3).

We question only Dr Duggal’s speculation that “AAs potentiate CBT.” CBT has been found to be useful in patients who receive standard neuroleptics, including those in our sample, as well as in patients receiving SGAs. Further, it may well be that SGAs and CBT do not potentiate one another but that their effects are additive. The 2 treatment modalities may be targeting different facets of schizophrenia. For example, CBT may teach or remediate coping skills, cognitive functions, and social adeptness impaired during acute psychosis; standard neuroleptics target positive symptoms, and SGAs target positive, negative, activation, dysphoria, and autistic preoccupation symptoms.

More work is needed to better understand whether the interaction between antipsychotics and CBT is additive or synergistic, as well as how CBT works with different antipsychotics.

References

1. Duggal HS. Combined use of atypical antipsychotics and cognitive-behavioural therapy in schizophrenia [letter]. Can J Psychiatry ;47:887–8.

2. White L, Harvey PD, Opler LA, Lindenmayer J-P, Bell M, Caton CLM, and others. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: a multisite multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale (PANSS). Psychopathology 1997;30:263–74.

3. Shelley AM, Battaglia J, Lucey J, Ellis A, Opler L. Symptom-specific group therapy for inpatients with schizophrenia. Einstein Quarterly:Journal of Biology and Medicine, 2001;18(1):21–8.

Anne-Marie Shelley, PhD
Lewis A Opler, MD, PhD
Joseph Battaglia, MD
Jeffrey Lucey, MD
Mount Vernon, New York




CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2002 | Index RCP des auteurs 2002
Subject Index to 2002 | Index RCP des sujets 2002
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil